These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 15897353)
1. Letters regarding article by Bloomfield et al, "microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy". Jachuck M; Satchithananda DK Circulation; 2005 May; 111(19):e299-300; author reply e299-300. PubMed ID: 15897353 [No Abstract] [Full Text] [Related]
2. Letters regarding article by Bloomfield et al, "microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy". Madias JE Circulation; 2005 May; 111(19):e299-300; author reply e299-300. PubMed ID: 15900622 [No Abstract] [Full Text] [Related]
3. Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: a solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum. Bloomfield DM; Steinman RC; Namerow PB; Parides M; Davidenko J; Kaufman ES; Shinn T; Curtis A; Fontaine J; Holmes D; Russo A; Tang C; Bigger JT Circulation; 2004 Oct; 110(14):1885-9. PubMed ID: 15451804 [TBL] [Abstract][Full Text] [Related]
4. Value of microvolt T-wave alternans for predicting patients who would benefit from implantable cardioverter-defibrillator therapy. Haghjoo M; Arya A; Sadr-Ameli MA Cardiol Rev; 2006; 14(4):173-9. PubMed ID: 16788329 [TBL] [Abstract][Full Text] [Related]
5. Utility of microvolt T-wave alternans to predict sudden cardiac death in patients with cardiomyopathy. Chauhan VS; Selvaraj RJ Curr Opin Cardiol; 2007 Jan; 22(1):25-32. PubMed ID: 17143041 [TBL] [Abstract][Full Text] [Related]
6. Prognostic value of T-wave alternans in patients with heart failure due to nonischemic cardiomyopathy: results of the ALPHA Study. Salerno-Uriarte JA; De Ferrari GM; Klersy C; Pedretti RF; Tritto M; Sallusti L; Libero L; Pettinati G; Molon G; Curnis A; Occhetta E; Morandi F; Ferrero P; Accardi F; J Am Coll Cardiol; 2007 Nov; 50(19):1896-904. PubMed ID: 17980258 [TBL] [Abstract][Full Text] [Related]
7. Prognostic utility of microvolt T-wave alternans in risk stratification of patients with ischemic cardiomyopathy. Chow T; Kereiakes DJ; Bartone C; Booth T; Schloss EJ; Waller T; Chung ES; Menon S; Nallamothu BK; Chan PS J Am Coll Cardiol; 2006 May; 47(9):1820-7. PubMed ID: 16682307 [TBL] [Abstract][Full Text] [Related]
8. Letter by De Ferrari and Verrier regarding article, "Role of microvolt T-wave alternans in assessment of arrhythmia vulnerability among patients with heart failure and systolic dysfunction: primary results from the T-wave alternans sudden cardiac death in heart failure trial substudy". De Ferrari GM; Verrier RL Circulation; 2009 Jul; 120(3):e20; author reply e22. PubMed ID: 19620521 [No Abstract] [Full Text] [Related]
9. Sudden cardiac death: the role of risk stratification. Kusmirek SL; Gold MR Am Heart J; 2007 Apr; 153(4 Suppl):25-33. PubMed ID: 17394900 [TBL] [Abstract][Full Text] [Related]
10. The ABCD (Alternans Before Cardioverter Defibrillator) Trial: strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention. Costantini O; Hohnloser SH; Kirk MM; Lerman BB; Baker JH; Sethuraman B; Dettmer MM; Rosenbaum DS; J Am Coll Cardiol; 2009 Feb; 53(6):471-9. PubMed ID: 19195603 [TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of a microvolt T-wave alternans screening strategy for implantable cardioverter-defibrillator placement in the MADIT-II-eligible population. Chan PS; Stein K; Chow T; Fendrick M; Bigger JT; Vijan S J Am Coll Cardiol; 2006 Jul; 48(1):112-21. PubMed ID: 16814657 [TBL] [Abstract][Full Text] [Related]
12. Utility of T-wave alternans in congestive heart failure. Deutsch A; Görenek B Anadolu Kardiyol Derg; 2007 Jul; 7 Suppl 1():82-4. PubMed ID: 17584689 [TBL] [Abstract][Full Text] [Related]
13. [Risk stratification for sudden cardiac death: from the electrophysiological study to T-wave alternans]. Pedretti RF; Sarzi Braga S; Vaninetti R; Laporta A; Masnaghetti S; Raimondo R; Rubin D; Santoro F; Salerno M G Ital Cardiol (Rome); 2008 Oct; 9(10 Suppl 1):33S-39S. PubMed ID: 19195304 [TBL] [Abstract][Full Text] [Related]
14. Sudden death prophylaxis in heart failure. Rosanio S; Schwarz ER; Vitarelli A; Zarraga IG; Kunapuli S; Ware DL; Birnbaum Y; Tuero E; Uretsky BF Int J Cardiol; 2007 Jul; 119(3):291-6. PubMed ID: 17208319 [TBL] [Abstract][Full Text] [Related]
16. Letter by Madias regarding article, "Role of microvolt T-wave alternans in assessment of arrhythmia vulnerability among patients with heart failure and systolic dysfunction: primary results from the T-wave alternans sudden cardiac death in heart failure trial substudy". Madias JE Circulation; 2009 Jul; 120(3):e21; author reply e22. PubMed ID: 19620522 [No Abstract] [Full Text] [Related]
18. Primary prevention with defibrillator therapy in women: results from the Sudden Cardiac Death in Heart Failure Trial. Russo AM; Poole JE; Mark DB; Anderson J; Hellkamp AS; Lee KL; Johnson GW; Domanski M; Bardy GH J Cardiovasc Electrophysiol; 2008 Jul; 19(7):720-4. PubMed ID: 18373605 [TBL] [Abstract][Full Text] [Related]
19. Microvolt T wave alternans (MTWA)--a new non-invasive predictor of sudden cardiac death. Predescu D; Mitruţ P; Giucă A Rom J Intern Med; 2004; 42(3):647-56. PubMed ID: 16366137 [TBL] [Abstract][Full Text] [Related]